- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
CTNNBL1 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP17056a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP17056a-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
CTNNBL1 Antibody (N-term) - Product info | |
| Application | WB
|
| Primary Accession | Q8WYA6 |
| Other Accession | NP_110517.2 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 65173 Da |
CTNNBL1 Antibody (N-term) - Additional info | |
| Gene ID 56259 | |
| Other Names CTNNBL1; C20orf33; Beta-catenin-like protein 1; Nuclear-associated protein; Testis development protein NYD-SP19 | |
| Target/Specificity This CTNNBL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 15-43 amino acids from the N-terminal region of human CTNNBL1. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions CTNNBL1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
CTNNBL1 Antibody (N-term) - Protein Information | |
| Name CTNNBL1 | |
| Synonyms C20orf33 | |
| Function Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. Participates in AID/AICDA-mediated Ig class switching recombination (CSR). May induce apoptosis | |
| Cellular Location Nucleus. | |
| Tissue Location Widely expressed with highest levels in skeletal muscle, placenta, heart, spleen, testis and thyroid | |
CTNNBL1 Antibody (N-term) - Related products
CTNNBL1 Antibody (N-term) - Application data
-
CTNNBL1 Antibody (N-term) (Cat. #AP17056a) western blot analysis in WiDr cell line lysates (35ug/lane).This demonstrates the CTNNBL1 antibody detected the CTNNBL1 protein (arrow).
CTNNBL1 Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The protein encoded by this gene contains an acidic domain, a putative bipartite nuclear localization signal, a nuclear export signal, a leucine-isoleucine zipper, and phosphorylation motifs. In addition, the encoded protein contains Armadillo/beta-catenin-like repeats, which have been implicated in protein-protein interactions. Although the function of this protein has not been determined, the C-terminal portion of the protein has been shown to possess apoptosis-inducing activity. [provided by RefSeq].
REFERENCES
Ichikawa, S., et al. J. Bone Miner. Res. 25(8):1821-1829(2010) Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Badiglian Filho, L., et al. Oncol. Rep. 21(2):313-320(2009) Andreasen, C.H., et al. BMC Med. Genet. 10, 17 (2009) : Vogel, C.I., et al. BMC Med. Genet. 10, 14 (2009) :